Skip to content

13F-HR filed by Redmile Group, LLC

Redmile Group, LLC filed this 13F-HR for the quarter ended 2014-12-31, filed 2015-02-18, with 54 holding rows worth $918,447,000.

Accession
0001597549-15-000003
Filed
2015-02-18
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2014

A holdings report, 54 entries on the cover page, a total value of $918,447,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $918,447,000 with VALUE read as thousands by filing date, 13F file number 028-12776. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
AMICUS THERAPEUTICS INC03152W109COM6,875,274$57,202,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock11,858,294$56,090,000thousands by filing date
VALEANT PHARMACEUTICALS INTL91911K102COM338,477$48,439,000thousands by filing date
CHIMERIX INC COM16934W106Stock1,157,184$46,588,000thousands by filing date
RITEAID CORP767754104COM6,038,734$45,411,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM721,632$40,411,000thousands by filing date
RECEPTOS, INC.756207106COMMON STOCK312,736$38,313,000thousands by filing date
CELGENE CORP151020104COM342,349$38,295,000thousands by filing date
AVALANCHE BIOT05337G107Common Stock699,070$37,750,000thousands by filing date
Gilead Sciences,Inc.375558103COM368,615$34,746,000thousands by filing date
SEATTLE GENETICS INC812578102COM983,966$31,615,000thousands by filing date
TRIVASCULAR TECHNOLOGIES INC89685A102COM1,755,568$22,067,000thousands by filing date
ZS PHARMA INC98979G105Common Stock524,702$21,812,000thousands by filing date
HEALTHWAYS INC422245100COM1,068,489$21,242,000thousands by filing date
STANDARD BIOTOOLS INC34385P108COM610,442$20,590,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR258,305$18,180,000thousands by filing date
MCKESSON CORP COM58155Q103Stock87,523$18,168,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK93,865$17,766,000thousands by filing date
NANOSTRING TECHNOLOGIES INC63009R109COM1,266,538$17,643,000thousands by filing date
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK990,810$17,488,000thousands by filing date
BELLICUM PHARMACEUTICALS INC079481107COM860,809$17,269,000thousands by filing date
NUVASIVE INC670704105COM358,679$16,915,000thousands by filing date
Lowes Companies Inc42222G108LOW309,045$16,543,000thousands by filing date
PROQR THERAPEUTICS NVN71542109SHS EURO751,171$15,729,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock1,012,371$15,661,000thousands by filing date
MODEL N INC607525102COM1,461,678$15,523,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock135,270$15,050,000thousands by filing date
CIVITAS SOLUTIONS INC17887R102COM879,485$14,978,000thousands by filing date
BIOGEN INC COM09062X103Stock43,113$14,635,000thousands by filing date
CASTLIGHT HEALTH INC CL B14862Q100Stock1,247,268$14,593,000thousands by filing date
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS1,070,995$14,587,000thousands by filing date
GLOBUS MED INC CL A379577208Stock611,731$14,541,000thousands by filing date
ACCURAY INC DEL004397105COM1,535,475$11,593,000thousands by filing date
ACHAOGEN INC004449104COM733,953$9,578,000thousands by filing date
BLUEBIRD BIO INC09609G100COM102,227$9,376,000thousands by filing date
NEVRO CORP64157F103COM234,254$9,059,000thousands by filing date
CONNECTURE INC COM20786J106Stock943,000$8,496,000thousands by filing date
ATARA BIOTHERAPEUTICS INC COM NEW046513107Stock264,266$7,069,000thousands by filing date
EHEALTH INC28238P109COM264,942$6,602,000thousands by filing date
FLEXION THERAPEUTICS INC33938J106COM315,144$6,363,000thousands by filing date
TOKAI PHARMACEUTICALS INC COM88907J107Stock215,139$3,171,000thousands by filing date
SESEN BIO, INC.286221106COM240,000$2,851,000thousands by filing date
ARRAY BIOPHARMA INC04269XAA3NOTE 3.000% 6/02,000,000$1,869,000thousands by filing dateprincipal
PACIFIC BIOSCIENCES CALIF INC COM69404D108Stock237,977$1,866,000thousands by filing date
LOXO ONCOLOGY INC548862101COM137,681$1,618,000thousands by filing date
FORWARD PHARMA A/S34986J105SPONSORED ADR25,235$526,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B103COM26,100$476,000thousands by filing date
MARKET VECTORS PHARM ETF T57060U217ETF6,500$418,000thousands by filing date
WELLCARE HEALTH PLANS INC94946T106COM4,887$401,000thousands by filing date
PowerShares QQQ Trust Unit Ser73935A104COM3,434$355,000thousands by filing date
ISHARES TR464287556ISHARES BIOTECH1,000$303,000thousands by filing date
ISHARES TR464288828US HLTHCR PR ETF2,500$296,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM1,390$257,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328601COM NEW25,000$64,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001597549-15-000003this filing2015-02-18acceptance time not in the bulk data set